Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial

David A. Palma, Suresh Senan, Mitchell Liu et al.|The Lancet|2019

Cited by 1.9k